Qing Kai Wen

Qing Kai Wen

Director/Board Member at REMEGEN CO., LTD.

Net worth: 1 M $ as of 31/05/2026

60 year
Health Technology
Consumer Services

Profile

Qing Kai Wen is currently Secretary & Executive Director at RemeGen Co., Ltd. since 2025, Director at MabPlex International Co., Ltd. since 2015, Director at Yantai Mabplex International Biomedical Co. Ltd. since 1995, Vice President at Rongchang Pharmaceuticals Ltd., and Member-Supervisory Board at Heyuan Aidisi Biomedical Technology Co. Ltd. Formerly, Mr. Wen was Vice President at Yantai Rongchang Pharmaceutical Co. Ltd. from 2004 to 2019.
Education includes a graduate degree from Zhejiang University conferred in 1995 and an undergraduate degree from Yangzhou University conferred in 1990.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/06/2026 118,150 ( 0.06% ) 1 M $ 31/05/2026

Qing Kai Wen active positions

CompaniesPositionStart
REMEGEN CO., LTD. Director/Board Member 02/04/2025
Corporate Officer/Principal 20/04/2011
Heyuan Aidisi Biomedical Technology Co. Ltd.
Director/Board Member -
Yantai Mabplex International Biomedical Co. Ltd.
Director/Board Member 01/05/1995
Director/Board Member 01/10/2015

Former positions of Qing Kai Wen

CompaniesPositionEnd
Yantai Rongchang Pharmaceutical Co. Ltd.
Corporate Officer/Principal 01/05/2019
See the detail of Qing Kai Wen's experience

Training of Qing Kai Wen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Yantai Rongchang Pharmaceutical Co. Ltd.

Heyuan Aidisi Biomedical Technology Co. Ltd.

Yantai Mabplex International Biomedical Co. Ltd.